Abstract
This short review tells the story of how Reversed Chloroquine drugs (RCQs) were developed. These are hybrid molecules, made by combining the quinoline nucleus from chloroquine (CQ) with moieties which are designed to inhibit efflux via known transporters in the membrane of the digestive vacuole of the malaria parasite. The resulting RCQ drugs can have potencies exceeding that of CQ, while at the same time having physical chemical characteristics that may make them favorable as partner drugs in combination therapies. The need for such novel antimalarial drugs will continue for the foreseeable future.
Keywords: Antimalarial, chloroquine, Plasmodium falciparum, drug development, drug design, structure activity relationship, malaria, drug resistance, Reversed Chloroquine drugs (RCQs), combination therapies
Current Topics in Medicinal Chemistry
Title: Reversed Chloroquine Molecules as a Strategy to Overcome Resistance in Malaria
Volume: 12 Issue: 5
Author(s): David H. Peyton
Affiliation:
Keywords: Antimalarial, chloroquine, Plasmodium falciparum, drug development, drug design, structure activity relationship, malaria, drug resistance, Reversed Chloroquine drugs (RCQs), combination therapies
Abstract: This short review tells the story of how Reversed Chloroquine drugs (RCQs) were developed. These are hybrid molecules, made by combining the quinoline nucleus from chloroquine (CQ) with moieties which are designed to inhibit efflux via known transporters in the membrane of the digestive vacuole of the malaria parasite. The resulting RCQ drugs can have potencies exceeding that of CQ, while at the same time having physical chemical characteristics that may make them favorable as partner drugs in combination therapies. The need for such novel antimalarial drugs will continue for the foreseeable future.
Export Options
About this article
Cite this article as:
H. Peyton David, Reversed Chloroquine Molecules as a Strategy to Overcome Resistance in Malaria, Current Topics in Medicinal Chemistry 2012; 12 (5) . https://dx.doi.org/10.2174/156802612799362968
DOI https://dx.doi.org/10.2174/156802612799362968 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Could Small Neurotoxins-Peptides be Expressed during SARS-CoV-2 Infection?
Current Genomics Amino Acid Transporter-Targeted Radiotracers for Molecular Imaging in Oncology
Current Medicinal Chemistry Understanding the Role of Corona Virus based on Current Scientific Evidence - A Review with Emerging Importance in Pandemic
Recent Patents on Anti-Infective Drug Discovery A Bioinorganic Perspective on Matrix Metalloproteinase Inhibition
Current Topics in Medicinal Chemistry Advanced Drug Delivery of N-Acetylcarnosine (N-Acetyl-beta-alanyl-Lhistidine), Carcinine (Beta-alanylhistamine) and L-carnosine (Beta-alanyl- L-histidine) in Targeting Peptide Compounds as Pharmacological Chaperones for Use in Tissue Engineering, Human Disease Management and Therapy: From in vitro to the Clinic
Recent Patents on Drug Delivery & Formulation Emerging Hsp90 Inhibitors: From Discovery to Clinic
Anti-Cancer Agents in Medicinal Chemistry Chronic Systemic Low-Grade Inflammation and Modern Lifestyle: The Dark Role of Gut Microbiota on Related Diseases with a Focus on COVID-19 Pandemic
Current Medicinal Chemistry Molecular Docking and 3D-QSAR Studies on Quinolone-based HDAC Inhibitors
Letters in Drug Design & Discovery Preface
Current Cancer Therapy Reviews The Cellular Protective Effects of Rosmarinic Acid: From Bench to Bedside
Current Neurovascular Research Crystallization and Preliminary X-Ray Crystallographic Studies on SICLP, a Novel Human Glyco_18 Domain – Containing Protein
Protein & Peptide Letters Graphical Abstracts:
Current Organic Chemistry Drug Targets from Human Pathogenic Amoebas: Entamoeba histolytica,Acanthamoeba polyphaga and Naegleria fowleri
Infectious Disorders - Drug Targets Structure and Function of RNase AS: A Novel Virulence Factor From Mycobacterium tuberculosis
Current Medicinal Chemistry An Efficient Gram-Scale Total Synthesis of Neoponkoranol as Potent α-Glucosidase Inhibitor
Current Organic Chemistry Oxytocin as a Potential Adjuvant Against COVID-19 Infection
Endocrine, Metabolic & Immune Disorders - Drug Targets A Review of Antifungal Natural Products Against the Pathogenic Fungi Causing Athletes' Foot Disease
Current Organic Chemistry Aminoglycosides with Anti-MRSA Activity: A Concise Review
Current Topics in Medicinal Chemistry Myositis Associated with the Anti-COVID-19 Covishield Vaccine
Current Respiratory Medicine Reviews Subject Index to Volume 1
Current Medicinal Chemistry - Cardiovascular & Hematological Agents